Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where R. Keller is active.

Publication


Featured researches published by R. Keller.


Clinical and Experimental Immunology | 2008

Mononuclear phagocytes from human bone marrow progenitor cells; morphology, surface phenotype, and functional properties of resting and activated cells

R. Keller; Ruth Keist; P. Joller; Peter Groscurth

After 3–4 weeks culture of human bone marrow cells in medium supplemented with IL‐3, macrophagc‐ (M‐CSF), and granulocyte‐macrophage colony‐stimulating factor (GM‐CSF), the firmly adherent cells exhibited the morphologic features of mononuclear phagocytes and were strongly esterase‐positive. Flow cylometric analysis revealed a rather homogeneous cell population with marked autofluorescence; the large majority of the cells expressed CD14. CD1 la,b, and c. Fc receptors for IgG, FcγRI, II, and III, and HLA class II molecules. Interfcron‐gamma (IFN‐γ). bacteria, and bacterial products modulated expression of some of the surface markers, induced and/ or enhanced respiratory burst, phagoeytic activity, secretion of tumour necrosis factor, and lumouricidal activity; in contrast, these cells were not able to generate reactive nitrogen intermediates.


Life Sciences | 1973

Suppression of growth of p-815 mastocytoma cells in vitro by drugs increasing cellular cyclic 3',5'-adenosine monophosphate.

R. Keller; Ruth Keist

Abstract The combined presence of dibutyryl cyclic 3′, 5′- adenosine monophosphate or adenyl cyclase activators and theophylline (which inhibits the breakdown of cyclic AMP) effectively suppressed the growth of a suspension culture of P-185 mastocytoma cells in vitro . As soon as the drugs were withdrawn from the culture, the growth of the tumour cells was fully restored. The observations are taken as support of the concept that cyclic AMP plays an important role in the control of cellular growth. The differences between the present findings and previous reports showing that these drugs had the reverse effect on certain normal cells may reflect differences between normal cells and tumour cells.


British Journal of Cancer | 1979

Competition between foetal tissue and macrophage-dependent natural tumour resistance.

R. Keller

Prolonged interaction in vitro between C. parvum-induced adherent predominantly phagocytic rat peritoneal cells and syngeneic or xenogeneic tumour targets consistently produces marked cytotoxicity. In the presence of irradiated foetal liver cells, expression of cytotoxicity is blocked in a dose-dependent manner. The ability of liver cells to compete with tumour targets is rapidly lost after birth. Irradiated liver cells from adult donors showed no such competition with tumour cells. The in vivo growth in ascites form of rat fibrosarcoma cells of low immunogenicity is significantly enhanced by irradiated foetal liver cells administered locally shortly before or on the day of tumour-cell challenge. The findings may provide an indication as to the nature of the structures recognized as non-self by mononuclear phagocytes.


International Journal of Cancer | 1990

Mechanisms of macrophage‐mediated tumor cell killing: A comparative analysis of the roles of reactive nitrogen intermediates and tumor necrosis factor

R. Keller; Ruth Keist; A. Wechsler; Thomas P. Leist; P. H. Van Der Meide


Immunology | 1972

Protective immunity to Nippostrongylus brasiliensis in the rat: central role of the lymphocyte in worm expulsion.

R. Keller; Ruth Keist


Journal of Immunology | 1987

Induction, maintenance, and reinduction of tumoricidal activity in bone marrow-derived mononuclear phagocytes by Corynebacterium parvum. Evidence for the involvement of a T cell- and interferon-gamma-independent pathway of macrophage activation.

R. Keller; Ruth Keist; P. H. Van Der Meide; P Groscurth; M Aguet; Thomas P. Leist


International Journal of Cancer | 1974

Functional and biochemical parameters of activation related to macrophage cytostatiic effects on tumor cells

R. Keller; Ruth Keist; R. J. Ivatt


Immunology | 1994

Macrophage response to bacteria and bacterial products: modulation of Fc gamma receptors and secretory and cellular activities.

R. Keller; Keist R; Joller Pw


International Journal of Cancer | 1986

Firm persistent binding between activated macrophages and tumor cells is not a prerequisite for the mediation of cytolysis.

R. Keller; Ruth Keist; Peter Groscurth


International Journal of Cancer | 1989

Discrepancy in the abilities of lymphokines and bacteria to mediate tumor protection in vivo and/or tumoricidal activity by macrophages in vitro

R. Keller; Ruth Keist; R. A. Schwendener

Collaboration


Dive into the R. Keller's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge